Purdue University scientists have identified the Supinoxin molecule as a possible new therapy for small cell lung cancer.

Higher baseline LTF levels in ES-SCLC patients may predict durable chemoimmunotherapy outcomes, suggesting LTF as a potential biomarker for treatment response. LTF appears to suppress SCLC tumors ...